Serum Uric Acid Level and Multiple Sclerosis: A Mendelian Randomization Study
Previous observational studies have shown that the serum uric acid (UA) level is decreased in persons with multiple sclerosis (MS). We used the two-sample Mendelian randomization (MR) method to determine whether the serum UA level is causally associated with the risk of MS. We screened 26 single-nuc...
Main Authors: | Peng-Peng Niu, Bo Song, Xue Wang, Yu-Ming Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2020.00254/full |
Similar Items
-
Serum Uric Acid Levels and Risk of Eight Site-Specific Cancers: A Mendelian Randomization Study
by: Minxiao Jiang, et al.
Published: (2021-03-01) -
Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis
by: Renxi Wang
Published: (2022-01-01) -
Association Between C-Reactive Protein and Risk of Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study
by: Yahui Zhu, et al.
Published: (2022-05-01) -
Unraveling the causality between chronic obstructive pulmonary disease and its common comorbidities using bidirectional Mendelian randomization
by: Zihan Wang, et al.
Published: (2024-02-01) -
A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
by: Lixian Ji, et al.
Published: (2023-07-01)